You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 804 Anti-tumor effect of a novel Vβ TCR-targeting bifunctional agent in combination with anti-PD1 in checkpoint refractory murine lung cancer models

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
804 Anti-tumor effect of a novel Vβ TCR-targeting bifunctional agent in combination with anti-PD1 in checkpoint refractory murine lung cancer models

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023124019
Dec 20232608
Jan 20241503
Feb 20241802
Mar 20241201
Apr 20241601
May 20241200
Jun 20243402
Jul 20241001
Aug 20241603
Sep 20242004
Oct 2024407
Nov 20244609
Dec 2024406
Jan 20251606
Feb 2025002
Mar 2025004
Apr 2025105
May 2025102
Jun 2025002
Total375087